Gilead Has Paid $178 Million to Doctors to Promote Drugs Despite Patient Deaths

Dilyana Gaytandzhieva

American pharmaceutical giant Gilead has paid at least $178 million to doctors and $81 million to hospitals in the US to promote and prescribe the company’s drugs despite cases of deaths and severe side effects. The drug-maker funded as many as 21,833 physicians in 2019 alone, according to data about Gilead payments from 2013 to 2019.

Deaths of patients in treatment with the Gilead hepatitis C antiviral Harvoni have been reported in the US, Canada, and Portugal, according to data obtained from the US Federal Drug Administration (FDA).

Despite the severe side effects from these Gilead hepatitis C antivirals the pharmaceutical company has listed none of them so that patients can make their informed decision.

Instead, Gilead has paid kickbacks to doctors to prescribe these drugs without patients being informed about the possible risks.

Latest articles

Bruce Scott In Part I of Menticide 101 and the Brainwashing of...
Bruce Scott It has become quite clear, especially during the last two...
Joseph Mercola Scientists warn repeated COVID boosters may result in lowered immunity...
Mitchell Brent Liester Chlorine dioxide has been condemned as a dangerous poison...
Paul Elkins The recent White House guidance for people to take the...
Igor Chudov The times are changing! Remember how we said that vaccine shedding...

Your donation helps us
stand up for health freedom!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.

Thank you!

The form has been submitted successfully!